Valuation — not yet established
No valuation for NeuroGeneces is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($425K) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·Watchlist + deal alerts for NeuroGeneces
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2025 | Seed Round | $425K | ▮ | ▮ |
| Dec 2021 | Accelerator/Incubator | — | ▮ | ▮ |
How NeuroGeneces's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For NeuroGeneces, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has NeuroGeneces raised?
- NeuroGeneces has raised $425K in total funding across 2 recorded rounds.
- When did NeuroGeneces last raise?
- NeuroGeneces last raised in Nov 2025 (Seed Round), raising $425K.